OVIDOvid Therapeutics Inc.
NASDAQ · Utilities · Large Cap · Mkt cap $64.3B · Vol 30.97M
$2.29
▼ -3.40% today
Fetching live price…
God's Eye forensics
Accounting quality and solvency screens. Anything that can't be computed from available filings data is left blank rather than estimated.
Piotroski F-Score
5/55
5 of 5 financial-health checks passed (4 checks need data this provider doesn't publish).
Altman Z-Score
Insufficient data—
Needs total assets, operating profit and debt — not published for this listing yet.
Beneish (earnings quality)
Insufficient data—
The full manipulation model needs two years of receivables, depreciation and accrual data, which isn't published for this listing.
Scores are free. The criteria-by-criteria breakdown — exactly which checks this company failed — is part of DeepScreen Pro.
Fundamental breakdown — raw ratios are free · fetching live data — showing modeled estimates for now
P/E Ratio (TTM)
Modeled8.2x
Cheap vs. earnings
Contextual insight — DeepScreen Pro
PEG Ratio
Modeled0.90
Undervalued vs. growth
Contextual insight — DeepScreen Pro
P/S Ratio
Modeled1.25x
Modest sales multiple
Contextual insight — DeepScreen Pro
P/B Ratio
Modeled1.74x
Reasonable
Contextual insight — DeepScreen Pro
EV/Revenue
Modeled1.09x
Low (value zone)
Contextual insight — DeepScreen Pro
EV/EBITDA
Modeled5.1x
Attractive
Contextual insight — DeepScreen Pro
ROE
Modeled21.2%
Excellent shareholder returns
Contextual insight — DeepScreen Pro
ROA
Modeled11.7%
Assets working hard
Contextual insight — DeepScreen Pro
ROCE
Modeled20.5%
High-quality compounder
Contextual insight — DeepScreen Pro
Debt / Equity
Modeled0.46x
Conservative balance sheet
Contextual insight — DeepScreen Pro
LT Debt / Equity
Modeled0.27x
Very low structural debt
Contextual insight — DeepScreen Pro
Payout Ratio
Modeled39%
Ideal balance — sustainable with room to reinvest
Contextual insight — DeepScreen Pro
Operating Leverage
Modeled2.71x
Profits amplify — both ways
Contextual insight — DeepScreen Pro
Company financials
- EPS (TTM)
- $0.28
- Revenue (TTM)
- $51.5B
- Net margin
- 15.3%
- EBITDA margin
- 21.3%
- Earnings growth
- 9.1%
- Dividend yield
- 4.76%
- Payout ratio
- 39%
- Debt / equity
- 0.46x
Live data hasn't loaded yet — figures shown are DeepScreen's modeled estimates.
OVID live news
LIVELoading live headlines…